These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 19829371)

  • 1. Multimodal techniques for diagnosis and prognosis of Alzheimer's disease.
    Perrin RJ; Fagan AM; Holtzman DM
    Nature; 2009 Oct; 461(7266):916-22. PubMed ID: 19829371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid biomarkers of Alzheimer's disease.
    Fagan AM; Holtzman DM
    Biomark Med; 2010 Feb; 4(1):51-63. PubMed ID: 20361010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current understanding of Alzheimer's disease diagnosis and treatment.
    Weller J; Budson A
    F1000Res; 2018; 7():. PubMed ID: 30135715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials.
    Ossenkoppele R; van der Kant R; Hansson O
    Lancet Neurol; 2022 Aug; 21(8):726-734. PubMed ID: 35643092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer's disease.
    Park SA; Han SM; Kim CE
    Exp Mol Med; 2020 Apr; 52(4):556-568. PubMed ID: 32284537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity.
    Hampel H; Mitchell A; Blennow K; Frank RA; Brettschneider S; Weller L; Möller HJ
    J Neural Transm (Vienna); 2004 Mar; 111(3):247-72. PubMed ID: 14991453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marking the markers of Alzheimer's: too good to diagnose, too bad to use?
    Olah Z; Pakaski M; Janka Z; Kalman J
    Neuropsychopharmacol Hung; 2012 Sep; 14(3):165-76. PubMed ID: 22987730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF biomarkers for Alzheimer's disease: current utility and potential future use.
    Holtzman DM
    Neurobiol Aging; 2011 Dec; 32 Suppl 1(Suppl 1):S4-9. PubMed ID: 22078172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Ritchie C; Smailagic N; Noel-Storr AH; Ukoumunne O; Ladds EC; Martin S
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010803. PubMed ID: 28328043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid τ protein in differential diagnosis of Alzheimer's disease and vascular dementia in Chinese population: a meta-analysis.
    Liu B; Tang Y; Shen Y; Cen L; Han M
    Am J Alzheimers Dis Other Demen; 2014 Mar; 29(2):116-22. PubMed ID: 24164930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in the Diagnosis and Prognosis of Alzheimer's Disease.
    Schaffer C; Sarad N; DeCrumpe A; Goswami D; Herrmann S; Morales J; Patel P; Osborne J
    J Lab Autom; 2015 Oct; 20(5):589-600. PubMed ID: 25424384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.
    Thijssen EH; La Joie R; Strom A; Fonseca C; Iaccarino L; Wolf A; Spina S; Allen IE; Cobigo Y; Heuer H; VandeVrede L; Proctor NK; Lago AL; Baker S; Sivasankaran R; Kieloch A; Kinhikar A; Yu L; Valentin MA; Jeromin A; Zetterberg H; Hansson O; Mattsson-Carlgren N; Graham D; Blennow K; Kramer JH; Grinberg LT; Seeley WW; Rosen H; Boeve BF; Miller BL; Teunissen CE; Rabinovici GD; Rojas JC; Dage JL; Boxer AL;
    Lancet Neurol; 2021 Sep; 20(9):739-752. PubMed ID: 34418401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.
    Toledo JB; Zetterberg H; van Harten AC; Glodzik L; Martinez-Lage P; Bocchio-Chiavetto L; Rami L; Hansson O; Sperling R; Engelborghs S; Osorio RS; Vanderstichele H; Vandijck M; Hampel H; Teipl S; Moghekar A; Albert M; Hu WT; Monge Argilés JA; Gorostidi A; Teunissen CE; De Deyn PP; Hyman BT; Molinuevo JL; Frisoni GB; Linazasoro G; de Leon MJ; van der Flier WM; Scheltens P; Blennow K; Shaw LM; Trojanowski JQ;
    Brain; 2015 Sep; 138(Pt 9):2701-15. PubMed ID: 26220940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease.
    Fagan AM; Perrin RJ
    Biomark Med; 2012 Aug; 6(4):455-76. PubMed ID: 22917147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: beta-amyloid(1-42), tau, phospho-tau-181 and total protein.
    Marksteiner J; Hinterhuber H; Humpel C
    Drugs Today (Barc); 2007 Jun; 43(6):423-31. PubMed ID: 17612711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer's Disease.
    Cioffi F; Adam RHI; Broersen K
    J Alzheimers Dis; 2019; 72(4):981-1017. PubMed ID: 31744008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease.
    Cohen AD; Landau SM; Snitz BE; Klunk WE; Blennow K; Zetterberg H
    Mol Cell Neurosci; 2019 Jun; 97():3-17. PubMed ID: 30537535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease.
    Prvulovic D; Hampel H
    Clin Chem Lab Med; 2011 Mar; 49(3):367-74. PubMed ID: 21342022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.